With regard to recombinant cytokines, IL-7 especially is attractive considering its ability to affect many different immune effector cells implicated in pathogen elimination (e.g., CD4 and CD8 T cells, and innate lymphoid cells) and to improve outcome in experimental sepsis. This evidence concerns the gene CD8A and Sepsis.